| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |